CAVERNOUS SINUS SYNDROME

CAVERNOUS SINUS SYNDROME was reported 27 times

These drug classes are most commonly taken by patients reporting CAVERNOUS SINUS SYNDROME:

# Drug Count
0 Corticosteroid [EPC] 10
1 Histamine-2 Receptor Antagonist [EPC] 5
2 Nonsteroidal Anti-inflammatory Drug [EPC] 5
3 Calcium Channel Blocker [EPC] 4
4 Dihydropyridine Calcium Channel Blocker [EPC] 4
5 Platelet Aggregation Inhibitor [EPC] 4
6 Benzodiazepine [EPC] 3
7 Insulin Analog [EPC] 3
8 Anti-epileptic Agent [EPC] 2
9 Atypical Antipsychotic [EPC] 2
10 Folate Analog Metabolic Inhibitor [EPC] 2
11 Histamine-1 Receptor Antagonist [EPC] 2
12 Nucleoside Metabolic Inhibitor [EPC] 2
13 P2Y12 Platelet Inhibitor [EPC] 2
14 Purine Antimetabolite [EPC] 2
15 Alkylating Drug [EPC] 1
16 Amide Local Anesthetic [EPC] 1
17 Aminosalicylate [EPC] 1
18 Androgen [EPC] 1
19 Angiotensin Converting Enzyme Inhibitor [EPC] 1
20 Antiarrhythmic [EPC] 1
21 Azole Antifungal [EPC] 1
22 CD20-directed Cytolytic Antibody [EPC] 1
23 CTLA-4-directed Blocking Antibody [EPC] 1
24 Calcium [EPC] 1
25 Complement Inhibitor [EPC] 1
26 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
27 Echinocandin Antifungal [EPC] 1
28 Endoglycosidase [EPC] 1
29 Ergot Derivative [EPC] 1
30 Fluoroquinolone Antibacterial [EPC] 1
31 GLP-1 Receptor Agonist [EPC] 1
32 HER2/neu Receptor Antagonist [EPC] 1
33 HMG-CoA Reductase Inhibitor [EPC] 1
34 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
35 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
36 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
37 Leukocyte Growth Factor [EPC] 1
38 Microtubule Inhibitor [EPC] 1
39 Platinum-based Drug [EPC] 1
40 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
41 Proton Pump Inhibitor [EPC] 1
42 Provitamin D2 Compound [EPC] 1
43 RANK Ligand Inhibitor [EPC] 1
44 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
45 Sulfonamide Antimicrobial [EPC] 1
46 Vitamin C [EPC] 1